# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-18-003257
Filing Date
2018-02-26
Accepted
2018-02-26 16:55:54
Documents
21
Period of Report
2018-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | abio-8k_20180226.htm | 8-K | 41455
2 | EX-99.1 | abio-ex991_6.htm | EX-99.1 | 25387
3 | EX-99.2 | abio-ex992_18.htm | EX-99.2 | 16397
4 | GRAPHIC | gtzg15y1izsu000006.jpg | GRAPHIC | 183058
5 | GRAPHIC | gtzg15y1izsu000009.jpg | GRAPHIC | 260244
6 | GRAPHIC | gtzg15y1izsu000002.jpg | GRAPHIC | 340815
7 | GRAPHIC | gtzg15y1izsu000014.jpg | GRAPHIC | 230264
8 | GRAPHIC | gtzg15y1izsu000013.jpg | GRAPHIC | 118411
9 | GRAPHIC | gtzg15y1izsu000012.jpg | GRAPHIC | 263390
10 | GRAPHIC | gtzg15y1izsu000005.jpg | GRAPHIC | 270698
11 | GRAPHIC | gtzg15y1izsu000004.jpg | GRAPHIC | 194379
12 | GRAPHIC | g2018022620064548319770.jpg | GRAPHIC | 20861
13 | GRAPHIC | gtzg15y1izsu000001.jpg | GRAPHIC | 377958
14 | GRAPHIC | gtzg15y1izsu000017.jpg | GRAPHIC | 368475
15 | GRAPHIC | gtzg15y1izsu000010.jpg | GRAPHIC | 216625
16 | GRAPHIC | gtzg15y1izsu000003.jpg | GRAPHIC | 182871
17 | GRAPHIC | gtzg15y1izsu000016.jpg | GRAPHIC | 185571
18 | GRAPHIC | gtzg15y1izsu000007.jpg | GRAPHIC | 289744
19 | GRAPHIC | gtzg15y1izsu000015.jpg | GRAPHIC | 192117
20 | GRAPHIC | gtzg15y1izsu000008.jpg | GRAPHIC | 249722
21 | GRAPHIC | gtzg15y1izsu000011.jpg | GRAPHIC | 342628
| Complete submission text file | 0001564590-18-003257.txt |  | 5991707

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 18641341
SIC: 2835 In Vitro & In Vivo Diagnostic Substances